Harvard Bioscience (HBIO) Share-based Compensation (2010 - 2026)
Harvard Bioscience (HBIO) reported Share-based Compensation of $257000.0 for Q1 2026, down 57.17% year-over-year from $600000.0 in Q1 2025, and down 44.01% quarter-over-quarter from $459000.0 in Q4 2025.
Harvard Bioscience (HBIO) Share-based Compensation (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Share-based Compensation data on file, last reported at $257000.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $257000.0, down 57.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $829000.0 (down 54.22% YoY), and the FY2025 annual result was $1.9 million, down 57.26% from the prior year.
- Share-based Compensation eased to $257000.0 in Q1 2026 per HBIO's latest filing, from $459000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $1.4 million in Q4 2023 and troughed at $18000.0 in Q3 2025.
- A 5-year average of $637764.7 and a median of $600000.0 in 2025 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 36.83% in 2023 and fell as far as 91.28% in 2023.
- A 5-year view of Share-based Compensation shows it stood at $1.0 million in 2022, then surged by 36.83% to $1.4 million in 2023, then plunged by 30.46% to $961000.0 in 2024, then slumped by 52.24% to $459000.0 in 2025, then slumped by 44.01% to $257000.0 in 2026.
- Business Quant data shows HBIO's Share-based Compensation at $257000.0 in Q1 2026, $459000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 209.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 58.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 23.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 26.79 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 6.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 51.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 40.92 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 10.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 257,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257,000.00 |
| Mar 31, 2026 | 257,000.00 |
| Dec 31, 2025 | 459,000.00 |
| Dec 31, 2025 | 459,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 961,000.00 |
| Dec 31, 2024 | 961,000.00 |
| Sep 30, 2024 | 124,000.00 |
| Sep 30, 2024 | 124,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Dec 31, 2023 | 1.38 Mn |